Next-Generation Sequencing for Lung Cancer in Clinical Practice
This video highlights some of the latest developments guiding precision medicine for lung cancer in clinical practice.
In this video, Ramaswamy Govindan, MD, of Washington University School of Medicine in St. Louis, gives highlights on a session covering precision medicine in lung cancer from the 2017 Multidisciplinary Thoracic Cancers Symposium, held March 16–18 in San Francisco.
During the session, Govindan gave a presentation on how deep sequencing and genomic testing can help guide therapy in clinical practice, including the use of cell-free DNA to detect EGFR-mutated lung cancer and how to avoid false negatives in these patients.
Neoadjuvant Capecitabine Plus Temozolomide in Atypical Lung NETs
Read about a woman with well-differentiated atypical carcinoid who experienced a 21% regression in primary tumor size after 12 months on neoadjuvant capecitabine and temozolomide.
